REDUCED licensing revenue, increased spending on branding, and research and development investments combined to send third-quarter net profit at medical devices group Biosensors International plunging 55 per cent to US$11.1 million (S$14 million).

Revenue for the three months ended Dec 31 rose 1 per cent over the same period last year, to reach US$82.5 million.

Earnings per share came in at 0.65 US cent, down from 1.41 US cents in the same period last year. Net asset value per share was 73.85 US cents as of Dec 31, up from 72.43 US cents as of March 31.